|
Puddu F, Oelschlaegel T, Guerini I, Geisler NJ, Niu H, Herzog M, et al. |
Synthetic viability genomic screening defines Sae2 function in DNA repair |
Thursday, April 23, 2015 |
The EMBO journal |
|
Pujari R, Hunte R, Thomas R, van der Weyden L, Rauch D, Ratner L, et al. |
Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for in... |
Tuesday, March 17, 2015 |
PLoS pathogens |
|
Pye RJ, Pemberton D, Tovar C, Tubio JM, Dun KA, Fox S, et al. |
A second transmissible cancer in Tasmanian devils |
Wednesday, December 30, 2015 |
Proceedings of the National Academy of Sciences of the United States of America |
|
Qian DC, Byun J, Han Y, Greene CS, Field JK, Hung RJ, et al. |
Identification of shared and unique susceptibility pathways among cancers o... |
Wednesday, October 21, 2015 |
Human molecular genetics |
|
Quigley D, Silwal-Pandit L, Dannenfelser R, Langerod A, Vollan HK, Vaske C,... |
Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wil... |
Thursday, October 30, 2014 |
Molecular cancer research : MCR |
|
R. Gilley;K. Balmanno;C. L. Cope;S. J. Cook |
Adaptation to chronic mTOR inhibition in cancer and in aging |
|
Biochem Soc Trans |
|
R. Rad;J. Cadinanos;L. Rad;I. Varela;A. Strong;L. Kriegl;F. Constantino-Cas... |
A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis... |
|
Cancer Cell |
|
R. Rad;J. Cadinanos;L. Rad;I. Varela;A. Strong;L. Kriegl;F. Constantino-Cas... |
A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis... |
|
Cancer Cell |
|
R.C. Jackson, G.Y. Di Veroli, S.B. Koh, I. Goldlust, F.M. Richards and D.I.... |
Modelling of the cancer cell cycle as a tool for rational drug development:... |
Thursday, May 4, 2017 |
PLoS Comput Biol |
|
Rabab Nasrallah, Charlotte J. Imianowski Lara Bossini-Castillo, Francis M. ... |
A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by ... |
Wednesday, July 1, 2020 |
Nature |
